Farther Finance Advisors »

4d Molecular Therapeutics In shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $222 11 20.27

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard S&p 500 Etf Etf (VOO)
Apple Stock (AAPL)
Uva Unconstrained Medium-term Fixed Income Etf Etf (FFIU)
Vanguard Short-term Bond Etf Etf (BSV)
Nvidia Corporation Stock (NVDA)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Microsoft Corp Stock (MSFT)
Vanguard Intermediate-term Bond Etf Etf (BIV)
Ishares Core Msci Eafe Etf Etf (IEFA)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Ishares Core S&p Small Cap Etf Etf (IJR)
Ishares National Muni Bond Etf Etf (MUB)
Ishares Msci Eafe Value Etf Etf (EFV)
Spdr Nuveen Bloomberg Short Term Municipal Bond Etf Etf (SHM)

View all positions for Farther Finance Advisors

Top funds holding 4d Molecular Therapeutics In

Viking Global Investors
RA Capital Management
BVF
VR Adviser
Henderson Group
Vanguard Group
Arrowpoint Asset Management
Casdin Capital
Goldman Sachs Group
Dimensional Fund Advisors
Deutsche Bank Aktiengesellschaft
Eagle Health Investments
Assenagon Asset Management
Jpmorgan Chase & Co
Point72 Asset Management

View all funds holding 4d Molecular Therapeutics In